Evidence map›Paper›PMID 34295648›Full record

ArticleUrology case reports2021

Endourological management of a rare radiopaque ritonavir-composed urinary calculus.

Folawiyo Laditi, Amir Ishaq Khan, Eric M Ghiraldi, Tashzna Jones, Ankur Choksi, Dinesh Singh

Open access · goldAbstract readCase Reports
In one paragraph

Article in Urology case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Folawiyo LaditiDepartment of Urology, Yale School of Medicine, 789 Howard Avenue, New Haven, CT, 06519, USA.
Amir Ishaq KhanDepartment of Urology, Yale School of Medicine, 789 Howard Avenue, New Haven, CT, 06519, USA.
Eric M GhiraldiDepartment of Urology, Yale School of Medicine, 789 Howard Avenue, New Haven, CT, 06519, USA.
Tashzna JonesDepartment of Urology, Yale School of Medicine, 789 Howard Avenue, New Haven, CT, 06519, USA.
Ankur ChoksiDepartment of Urology, Yale School of Medicine, 789 Howard Avenue, New Haven, CT, 06519, USA.
Dinesh SinghDepartment of Urology, Yale School of Medicine, 789 Howard Avenue, New Haven, CT, 06519, USA.
Yale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protease inhibitors are a source of nephrolithiasis in HIV + patients, and these stones are described as not detected by CT. While urinary stones are commonly associated with certain protease inhibitors, stones composed of ritonavir are rare. We present the case of a 58-year-old female on ritonavir-boosted atazanavir who presented to our clinic complaining of gross hematuria and flank pain secondary to a ureteral stone. Surgical removal revealed the stone to be composed of 100% ritonavir with no usual urinary stone components. This is the first report of an HIV medicine stone being detectable by CT scan described as 100% ritonavir.

Indexed as

ATV/r, ritonavir-boosted atazanavirCTCT, computed tomographyEndourologyHIV/AIDSKidney stonePI, protease inhibitorRitonavirUrolithiasisUVJ, uterovesicular junction

Identifiers

PMID34295648
PMCPMC8281602
OpenAlexW3175072259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.